(Q41378943)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25701453%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

title

Phase II study of interim PET-CT-guided response-adapted therapy in advanced Hodgkin's lymphoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25701453%20AND%20SRC:MED&resulttype=core&format=json

Venkatraman Radhakrishnan

1 March 2020

author

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25701453%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

author name string

P Ganesan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25701453%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

R Rajendranath

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25701453%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

K Kannan

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25701453%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

T S Ganesan

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25701453%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

K Udupa

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25701453%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

K M Lakshmipathy

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25701453%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

V Mahajan

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25701453%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

S Sundersingh

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25701453%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

S Rajaraman

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25701453%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

R Krishnakumar

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25701453%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

T G Sagar

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25701453%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

publication date

20 February 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25701453%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25701453%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25701453%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25701453%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

page(s)

1170-1174

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25701453%20AND%20SRC:MED&resulttype=core&format=json

Survival in Hodgkin's disease patients--report of 25 years of experience at the Milan Cancer Institute

1 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV077

Treatment of Hodgkin lymphoma: a 50-year perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV077

Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV077

Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV077

Hodgkin's lymphoma--long-term outcome: an experience from a tertiary care cancer center in North India.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV077

ABVD (8 cycles) versus BEACOPP (4 escalated cycles ≥ 4 baseline): final results in stage III-IV low-risk Hodgkin lymphoma (IPS 0-2) of the LYSA H34 randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV077

Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV077

Escalated-dose BEACOPP in the treatment of patients with advanced-stage Hodgkin's lymphoma: 10 years of follow-up of the GHSG HD9 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV077

Eight cycles of escalated-dose BEACOPP compared with four cycles of escalated-dose BEACOPP followed by four cycles of baseline-dose BEACOPP with or without radiotherapy in patients with advanced-stage hodgkin's lymphoma: final analysis of the HD12 t

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV077

International Prognostic Score in advanced-stage Hodgkin's lymphoma: altered utility in the modern era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV077

A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV077

The predictive role of interim positron emission tomography for Hodgkin lymphoma treatment outcome is confirmed using the interpretation criteria of the Deauville five-point scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV077

Early interim 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin's lymphoma: a report from a joint Italian-Danish study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV077

Early chemotherapy intensification with BEACOPP in advanced-stage Hodgkin lymphoma patients with a interim-PET positive after two ABVD courses

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV077

Report on the Third International Workshop on Interim Positron Emission Tomography in Lymphoma held in Menton, France, 26-27 September 2011 and Menton 2011 consensus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV077

Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV077

International validation study for interim PET in ABVD-treated, advanced-stage hodgkin lymphoma: interpretation criteria and concordance rate among reviewers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV077

Dose-intensive response-based chemotherapy and radiation therapy for children and adolescents with newly diagnosed intermediate-risk hodgkin lymphoma: a report from the Children's Oncology Group Study AHOD0031

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV077

Comparison of various criteria in interpreting end of therapy F-18 labeled fluorodeoxyglucose positron emission tomography/computed tomography in patients with aggressive non-Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV077

21 January 2018

Identifiers

DOI

10.1093/ANNONC/MDV077

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25701453%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

1 reference